FDA
Articles tagged with “FDA”
4 articles
FDA Review of Preservative-Free Ketamine Advances
NRx Pharmaceuticals reports progress on FDA review of its preservative-free ketamine application. Here's what it could mean for troche access and compounding.
Read
news
NRx's FDA Push for Preservative-Free Ketamine Explained
NRx Pharmaceuticals reports FDA progress on a preservative-free ketamine application. Here's what it means for troche access, compounding, and home dosing.
vs-other-methods
Compounded Ketamine vs. Brand-Name Spravato: Full Comparison
Compare compounded racemic ketamine (troches, nasal spray) with FDA-approved Spravato (esketamine) on efficacy, cost, FDA approval, access, and clinical suitability.
what-are-troches
FDA Status of Compounded Ketamine Troches
Compounded ketamine troches are not FDA-approved but are legal under 503A compounding law. Understand prescriber liability, regulatory status, and what this means for patients.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.